Positions

Overview

  • Dr. Sung is originally from Houston, TX and completed his undergraduate degree in Neuroscience from Vanderbilt University. He completed medical school at UT-Southwestern Medical Center at Dallas and completed neurology residency and movement disorders fellowship at UAB. He joined faculty in the UAB Department of Neurology, Division of Movement Disorders and has the rank of Associate Professor with Tenure. He is the Director of the UAB Huntington's Disease Clinic, Co-Director of the UAB School of Medicine Neuroscience Module, and is the Director of the Birmingham VAMC Deep Brain Stimulation Program. Dr. Sung received the President's Award for Excellence in Teaching in 2019 and received the A.B. Baker Outstanding Teacher of the Year Award from the American Academy of Neurology for 2021. He serves on the National Board of Trustees of the Huntington's Disease Society of America, currently serving as Chair of the Board from 2021-23.
  • Selected Publications

    Chapter

    Year Title Altmetric
    2016 Pharmacology of dopaminergic neurotransmission 2016

    Research Overview

  • Huntington's Disease
  • Principal Investigator On

  • Development of Assessments for Later Stage Huntington's Disease: UHDRS Structured Interview of Function and HD Clinical Status Questionnaire  awarded by CHDI Foundation 2020 - 2025
  • Private Grant  awarded by NEUROCRINE BIOSCIENCES INC 2021 - 2025
  • Private Grant  awarded by Genentech 2019 - 2023
  • An Exploratory Phase II Study to Determine the Tolerability, Safety, and Activity of a Novel Vasopressin 1a Receptor Antagonist (SRX246) in Irritable Subjects with Huntington's Disease (HD)  awarded by MASSACHUSETTS GENERAL HOSPITAL 2016 - 2023
  • Private Grant  awarded by Genentech 2019 - 2023
  • Private Grant  awarded by NEUROCRINE BIOSCIENCES INC 2020 - 2022
  • Huntington's Disease Society of America Centers of Excellence Program 2018  awarded by Huntington's Disease Society of America, Inc. 2018 - 2021
  • Private Grant  awarded by VACCINEX, INC. 2015 - 2021
  • Enroll-HD: A Prospective Registry Study in a Global Huntington's Disease Cohort A CHDI Foundation Project  awarded by CHDI Foundation 2012 - 2019
  • Private Grant  awarded by Pfizer Inc., U.S. Pharmaceuticals Group 2015 - 2019
  • Private Grant  awarded by AUSPEX PHARMACEUTICALS, INC. 2013 - 2018
  • Private Grant  awarded by Pfizer Pharmaceuticals 2014 - 2018
  • Private Grant  awarded by AUSPEX PHARMACEUTICALS, INC. 2013 - 2018
  • 2015 Huntington's Disease Society of America Centers of Excellence Program  awarded by Huntington's Disease Society of America, Inc. 2015 - 2017
  • Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)  awarded by MASSACHUSETTS GENERAL HOSPITAL 2014 - 2015
  • 2014 HDSA Center of Excellence Grant  awarded by Huntington's Disease Society of America, Inc. 2014
  • Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)  awarded by MASSACHUSETTS GENERAL HOSPITAL 2011 - 2014
  • 2013 HDSA Center of Excellence Grant Application  awarded by Huntington's Disease Society of America, Inc. 2013
  • Investigator On

  • The Parkinson’s Progression Markers Initiative (PPMI) 2.0 Clinical - Establishing a Deeply Phenotyped PD Cohort  awarded by Fox (Michael J.) Foundation for Parkinson's Research 2020 - 2033
  • The Parkinson's Progression Marker's Initiative (PPMI)  awarded by Fox (Michael J.) Foundation for Parkinson's Research 2010 - 2023
  • Noninvasive Biomarkers to Advance Emerging DBS Electrode Technologies in Parkinson’s Disease  awarded by National Institute of Neurological Disorders and Stroke/NIH/DHHS 2016 - 2023
  • Private Grant  awarded by ANNEXON BIOSCIENCES INC 2020 - 2022
  • Private Grant  awarded by BOSTON SCIENTIFIC CORPORATION 2017 - 2022
  • Private Grant  awarded by MedImmune 2015 - 2021
  • The Edmond J. Safra Visiting Nurse Faculty Program at the Parkinson Disease Foundation  awarded by National Parkinson Foundation, Inc. 2017 - 2019
  • Clinician-input Study: How the Fox Wearable Companion Mobile Application can Influence Treatment and Care (CIS-PD)  awarded by Fox (Michael J.) Foundation for Parkinson's Research 2017 - 2018
  • Post-Stroke Aphasia and rTMS Treatment (PART) Study  awarded by National Institute of Child Health and Human Development/NIH/DHHS 2012 - 2018
  • Private Grant  awarded by AVANIR PHARMACEUTICALS, INC. 2016 - 2018
  • Functional Change in Mild Cognitive Impairment  awarded by National Institute on Aging/NIH/DHHS 2010 - 2017
  • Fox Investigation for New Discovery of Biomarkers (BioFIND)  awarded by Fox (Michael J.) Foundation for Parkinson's Research 2014 - 2015
  • 2012 HDSA Center of Excellence Grant  awarded by Huntington's Disease Society of America, Inc. 2011 - 2012
  • Education And Training

  • Doctor of Medicine, University of Texas System : Southwestern Medical Center at Dallas 2005
  • John Peter Smith Hospital, Internship 2006
  • John Peter Smith Hospital, Internship 2006
  • UAB Hospital, Residency 2009
  • University of Alabama at Birmingham Neurology, Residency 2009
  • University of Alabama at Birmingham, Postdoctoral Fellowship 2011
  • Full Name

  • Victor Sung